{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:28:14Z","timestamp":1784730494490,"version":"3.55.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.msard.2026.107091","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:00:22Z","timestamp":1771866022000},"page":"107091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Multiple sclerosis and autoimmunity: learnings from post-streptococcal autoimmunity"],"prefix":"10.1016","volume":"109","author":[{"given":"Benjamin Michael","family":"Bloom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Valero-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angray S.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5196-3064","authenticated-orcid":false,"given":"Bavneet Kaur","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Cutino-Moguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Selwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa K.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9995-1700","authenticated-orcid":false,"given":"Gavin","family":"Giovannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107091_bib0002","article-title":"Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosis","author":"Abdelhak","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.msard.2026.107091_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(22)00471-9","article-title":"Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy","author":"Aloisi","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107091_bib0004","doi-asserted-by":"crossref","first-page":"132","DOI":"10.12688\/f1000research.144903.2","article-title":"Unveiling the group A Streptococcus vaccine-based l-rhamnose from backbone of group A carbohydrate: current insight against acute rheumatic fever to reduce the global burden of rheumatic heart disease","volume":"13","author":"Ambari","year":"2024","journal-title":"F1000Res"},{"key":"10.1016\/j.msard.2026.107091_bib84","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","article-title":"Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis","volume":"17","author":"Armangue","year":"2018","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.msard.2026.107091_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578383","article-title":"Infection, vaccination and narcolepsy type 1: evidence and potential molecular mechanisms","volume":"393","author":"Ayoub","year":"2024","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107091_bib0006","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1074-7613(00)80622-6","article-title":"EBV persistence in memory B cells in vivo","volume":"9","author":"Babcock","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.msard.2026.107091_bib0007","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ebiom.2017.01.042","article-title":"Memory B cells are major targets for effective immunotherapy in relapsing multiple sclerosis","volume":"16","author":"Baker","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.msard.2026.107091_bib0008","first-page":"13","article-title":"Epstein-Barr virus-associated malignancies and immune escape: the role of the tumor microenvironment and tumor cell evasion strategies","author":"Bauer","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.msard.2026.107091_bib0009","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa2102074","article-title":"Secondary antibiotic prophylaxis for latent rheumatic heart disease","volume":"386","author":"Beaton","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2026.107091_bib0010","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.msard.2026.107091_bib0011","article-title":"Long-term antibiotic prophylaxis for prevention of rheumatic fever recurrence and progression to rheumatic heart disease","volume":"9","author":"Bray","year":"2024","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.msard.2026.107091_bib0012","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0002-9343(54)90219-3","article-title":"The role of the streptococcus in the pathogenesis of rheumatic fever","volume":"17","author":"Catanzaro","year":"1954","journal-title":"Am. J. Med."},{"key":"10.1016\/j.msard.2026.107091_bib0013","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1189\/jlb.0313173","article-title":"Innate immune responses against Epstein Barr virus infection","volume":"94","author":"Chijioke","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.msard.2026.107091_bib0015","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.celrep.2013.11.041","article-title":"Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection","volume":"5","author":"Chijioke","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.msard.2026.107091_bib0014","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fimmu.2016.00323","article-title":"NK cell influence on the outcome of primary Epstein-Barr Virus infection","volume":"7","author":"Chijioke","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107091_bib0016","doi-asserted-by":"crossref","first-page":"s533","DOI":"10.2741\/1067","article-title":"Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease","volume":"8","author":"Cunningham","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.msard.2026.107091_bib0017","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/BOR.0b013e32835461d3","article-title":"Streptococcus and rheumatic fever","volume":"24","author":"Cunningham","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.msard.2026.107091_bib0018","series-title":"Basic Biology to Clinical Manifestations","article-title":"Post-streptococcal autoimmune sequelae: rheumatic fever and beyond","author":"Cunningham","year":"2016"},{"key":"10.1016\/j.msard.2026.107091_bib0019","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02444-23","article-title":"Epstein-Barr virus induces germinal center light zone chromatin architecture and promotes survival through enhancer looping at the locus","volume":"15","author":"Dai","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.msard.2026.107091_bib0020","first-page":"211","article-title":"Infectious mononucleosis","volume":"390","author":"Dunmire","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.msard.2026.107091_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104434","article-title":"What are T-cells telling us about how EBV causes MS?","volume":"68","author":"Giovannoni","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107091_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103636","article-title":"Is EBV the cause of multiple sclerosis?","volume":"58","author":"Giovannoni","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107091_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106337","article-title":"Infectious mononucleosis is a more realistic target for preventing multiple sclerosis","volume":"95","author":"Giovannoni","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107091_bib0028","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awaf170","article-title":"The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis","author":"Giovannoni","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107091_bib0021","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.msard.2016.02.010","article-title":"How long is the presymptomatic phase of multiple sclerosis?","volume":"7","author":"Giovannoni","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107091_bib0022","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(17)30127-8","article-title":"The neurodegenerative prodrome in multiple sclerosis","volume":"16","author":"Giovannoni","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107091_bib0023","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/WCO.0000000000001266","article-title":"Targeting Epstein-Barr virus in multiple sclerosis: when and how?","volume":"37","author":"Giovannoni","year":"2024","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.msard.2026.107091_bib0024","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/brain\/awaf027","article-title":"EBV-specific T-cell responses are telling us something important about multiple sclerosis","volume":"148","author":"Giovannoni","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107091_bib0029","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/01.CIR.72.6.1155","article-title":"The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones memorial lecture","volume":"72","author":"Gordis","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.msard.2026.107091_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577548","article-title":"Potential autoimmune encephalitis following yellow fever vaccination: a report of three cases","volume":"355","author":"Guedes","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107091_bib0031","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coviro.2021.11.013","article-title":"Epigenetic control of the Epstein-Barr lifecycle","volume":"52","author":"Guo","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.msard.2026.107091_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70785","article-title":"Epstein-Barr Virus (EBV) and autoimmune diseases: pathogenic mechanisms and therapeutic insights","volume":"98","author":"Gupta","year":"2026","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.msard.2026.107091_bib0033","series-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","article-title":"The epidemiology of EBV and its association with malignant disease","author":"Hjalgrim","year":"2007"},{"key":"10.1016\/j.msard.2026.107091_bib0034","series-title":"Epstein-Barr Virus","author":"Hoover","year":"2025"},{"key":"10.1016\/j.msard.2026.107091_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.01.003","article-title":"Antibiotics to eradicate Streptococcus pyogenes pharyngeal carriage in asymptomatic children and adults: a systematic review","volume":"88","author":"Hung","year":"2024","journal-title":"J. Infect."},{"key":"10.1016\/j.msard.2026.107091_bib0037","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.meegid.2018.03.006","article-title":"Streptococcal pharyngitis and rheumatic heart disease: the superantigen hypothesis revisited","volume":"61","author":"Hurst","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.msard.2026.107091_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010097","article-title":"Streptococcal superantigens and the return of scarlet fever","volume":"17","author":"Hurst","year":"2021","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.msard.2026.107091_bib0038","series-title":"Biological Agents. International Agency For Research on Cancer","article-title":"Working Group on the evaluation of carcinogenic risks to humans","year":"2012"},{"key":"10.1016\/j.msard.2026.107091_bib0039","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/BOR.0000000000000505","article-title":"Autoimmune manifestations of infections","volume":"30","author":"Jara","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.msard.2026.107091_bib0040","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/clinchem\/45.5.616","article-title":"When is a heterophile antibody not a heterophile antibody? When it is an antibody against a specific immunogen","volume":"45","author":"Kaplan","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.msard.2026.107091_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/cells11172757","article-title":"Altered immune response to the Epstein-Barr Virus as a prerequisite for multiple sclerosis","volume":"11","author":"L\u00e4derach","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.msard.2026.107091_bib0042","doi-asserted-by":"crossref","DOI":"10.3390\/cells11172757","article-title":"Altered immune response to the Epstein-Barr Virus as a prerequisite for multiple sclerosis","volume":"11","author":"L\u00e4derach","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.msard.2026.107091_bib0044","doi-asserted-by":"crossref","first-page":"e1438","DOI":"10.1002\/cti2.1438","article-title":"Roadmap for understanding mechanisms on how Epstein-Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trials","volume":"12","author":"Lanz","year":"2023","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.msard.2026.107091_bib0043","doi-asserted-by":"crossref","first-page":"e1438","DOI":"10.1002\/cti2.1438","article-title":"Roadmap for understanding mechanisms on how Epstein-Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trials","volume":"12","author":"Lanz","year":"2023","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.msard.2026.107091_bib0045","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","article-title":"The Guillain-Barr\u00e9 syndrome and the 1992-1993 and 1993-1994 influenza vaccines","volume":"339","author":"Lasky","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2026.107091_bib0046","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1093\/cid\/ciab180","article-title":"Serological profiling of group A Streptococcus infections in acute rheumatic fever","volume":"73","author":"Lorenz","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.msard.2026.107091_bib0047","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00415-017-8501-4","article-title":"Japanese encephalitis can trigger anti-N-methyl-D-aspartate receptor encephalitis","volume":"264","author":"Ma","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107091_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.887794","article-title":"The potential for EBV vaccines to prevent multiple sclerosis","volume":"13","author":"Maple","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2026.107091_bib0049","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.tig.2021.04.012","article-title":"Multiple sclerosis: doubling down on MHC","volume":"37","author":"Martin","year":"2021","journal-title":"Trends. Genet."},{"key":"10.1016\/j.msard.2026.107091_bib0050","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.tig.2021.04.012","article-title":"Multiple sclerosis: doubling down on MHC","volume":"37","author":"Martin","year":"2021","journal-title":"Trends. Genet."},{"key":"10.1016\/j.msard.2026.107091_bib0051","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410260508","article-title":"The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord","volume":"26","author":"Miller","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2026.107091_bib0052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2026.107091_bib0053","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1073858410381531","article-title":"The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis","volume":"17","author":"Pender","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.msard.2026.107091_bib0054","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/qjmed\/hci149","article-title":"Risk and predictors of fatigue after infectious mononucleosis in a large primary-care cohort","volume":"99","author":"Petersen","year":"2006","journal-title":"QJM."},{"key":"10.1016\/j.msard.2026.107091_bib0055","doi-asserted-by":"crossref","first-page":"11096","DOI":"10.1128\/JVI.01069-12","article-title":"Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-\u03bab activation","volume":"86","author":"Price","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.msard.2026.107091_bib0056","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00428-022-03414-4","article-title":"New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders","volume":"482","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch."},{"key":"10.1016\/j.msard.2026.107091_bib0057","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1474-4422(10)70094-6","article-title":"Multiple sclerosis: risk factors, prodromes, and potential causal pathways","volume":"9","author":"Ramagopalan","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107091_bib0058","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","article-title":"Campylobacter jejuni infection and Guillain-Barr\u00e9 syndrome","volume":"333","author":"Rees","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2026.107091_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103070","article-title":"Molecular mimicry and autoimmunity in the time of COVID-19","volume":"139","author":"Rojas","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.msard.2026.107091_bib0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2014.04.005","article-title":"Multiple sclerosis: the elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1","volume":"272","author":"Ruprecht","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107091_bib0061","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2424986122","article-title":"Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls","volume":"122","author":"Sattarnezhad","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U S. A"},{"key":"10.1016\/j.msard.2026.107091_bib0062","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/brain\/awae244","article-title":"Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation","volume":"148","author":"Schneider-Hohendorf","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107091_bib0063","first-page":"23","article-title":"Comparative evaluation of seven commercial tests for detection of heterophile antibody in infectious mononucleosis","volume":"3","author":"Skulnick","year":"1992","journal-title":"Can. J. Infect. Dis."},{"key":"10.1016\/j.msard.2026.107091_bib0064","doi-asserted-by":"crossref","DOI":"10.3390\/v11080762","article-title":"Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms","volume":"11","author":"Smatti","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.msard.2026.107091_bib0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"21","author":"Soldan","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.msard.2026.107091_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111286","article-title":"Time-resolved transcriptomes reveal diverse B cell fate trajectories in the early response to Epstein-Barr virus infection","volume":"40","author":"SoRelle","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.msard.2026.107091_bib0068","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1001145","article-title":"Epstein-Barr virus perpetuates B cell germinal center dynamics and generation of autoimmune-associated phenotypes","volume":"13","author":"SoRelle","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107091_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112958","article-title":"Epstein-Barr virus evades restrictive host chromatin closure by subverting B cell activation and germinal center regulatory loci","volume":"42","author":"SoRelle","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.msard.2026.107091_bib0069","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/08916930500484922","article-title":"Molecular mimicry in multiple sclerosis","volume":"39","author":"Sospedra","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.msard.2026.107091_bib0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/08916930500484922","article-title":"Molecular mimicry in multiple sclerosis","volume":"39","author":"Sospedra","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.msard.2026.107091_bib0071","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ihj.2013.12.017","article-title":"Preventing rheumatic fever: m-protein based vaccine","volume":"66","author":"Tandon","year":"2014","journal-title":"Indian Heart J."},{"key":"10.1016\/j.msard.2026.107091_bib0072","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.20161846","article-title":"Human immunity against EBV-lessons from the clinic","volume":"214","author":"Tangye","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.msard.2026.107091_bib0073","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis","volume":"59","author":"Thacker","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2026.107091_bib0074","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.665718","article-title":"The CD8 T cell-Epstein-Barr Virus-B cell trialogue: a Central issue in multiple sclerosis pathogenesis","volume":"12","author":"Veroni","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107091_bib0075","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1016\/j.cell.2023.11.015","article-title":"Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis","volume":"186","author":"Vietzen","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.msard.2026.107091_bib0076","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184481","article-title":"Accumulation of Epstein-Barr virus-induced cross-reactive immune responses is associated with multiple sclerosis","volume":"134","author":"Vietzen","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.msard.2026.107091_bib0077","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.1038\/s41467-025-61751-9","article-title":"Early identification of individuals at risk for multiple sclerosis by quantification of EBNA-1-specific antibody titers","volume":"16","author":"Vietzen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.msard.2026.107091_bib0078","article-title":"HLA-DR expression level in CD8 T cells correlates with the severity of children with acute infectious mononucleosis","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107091_bib0001","series-title":"WHO Guideline On the Prevention and Diagnosis of Rheumatic Fever and Rheumatic Heart Disease","year":"2024"},{"key":"10.1016\/j.msard.2026.107091_bib0079","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1474-4422(17)30076-5","article-title":"Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study","volume":"16","author":"Wijnands","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107091_bib0080","doi-asserted-by":"crossref","DOI":"10.1128\/asmcr.00025-24","article-title":"Anti-NMDA receptor encephalitis following Murray Valley encephalitis: a case report","volume":"1","author":"Yerramilli","year":"2025","journal-title":"ASM Case. Rep."},{"key":"10.1016\/j.msard.2026.107091_bib0081","doi-asserted-by":"crossref","first-page":"eady0210","DOI":"10.1126\/scitranslmed.ady0210","article-title":"Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus","volume":"17","author":"Younis","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.msard.2026.107091_bib0082","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41591-024-02938-3","article-title":"An autoantibody signature predictive for multiple sclerosis","volume":"30","author":"Zamecnik","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.msard.2026.107091_bib0083","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/13524585251340812","article-title":"The path to prevention of multiple sclerosis: considerations for Epstein-Barr virus vaccine-based prevention studies","volume":"31","author":"Zane","year":"2025","journal-title":"Mult. Scler."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826001276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826001276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:24:37Z","timestamp":1781526277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826001276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":84,"alternative-id":["S2211034826001276"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107091","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple sclerosis and autoimmunity: learnings from post-streptococcal autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107091"}}